Lam Research (NASDAQ:LRCX) Rating Increased to Moderate Buy at Royal Bank Of Canada

Lam Research (NASDAQ:LRCX) was upgraded by stock analysts at Royal Bank Of Canada to a “moderate buy” rating in a research note issued on Wednesday,Zacks.com reports.

LRCX has been the topic of several other reports. TD Cowen increased their price objective on Lam Research from $145.00 to $170.00 and gave the company a “buy” rating in a research note on Thursday, October 23rd. Citigroup increased their price target on Lam Research from $175.00 to $190.00 and gave the company a “buy” rating in a research report on Tuesday, November 11th. Jefferies Financial Group reiterated a “buy” rating and issued a $200.00 price objective (up previously from $175.00) on shares of Lam Research in a research note on Monday, December 15th. Deutsche Bank Aktiengesellschaft boosted their price objective on Lam Research from $160.00 to $195.00 and gave the stock a “buy” rating in a research report on Friday, December 19th. Finally, JPMorgan Chase & Co. raised their target price on shares of Lam Research from $113.00 to $165.00 and gave the company an “overweight” rating in a report on Thursday, October 23rd. One analyst has rated the stock with a Strong Buy rating, twenty-seven have assigned a Buy rating and eight have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Lam Research currently has a consensus rating of “Moderate Buy” and a consensus price target of $189.55.

Lam Research Trading Up 4.2%

Shares of LRCX stock opened at $217.47 on Wednesday. Lam Research has a fifty-two week low of $56.32 and a fifty-two week high of $229.57. The company has a 50 day moving average price of $170.33 and a 200 day moving average price of $136.11. The stock has a market capitalization of $273.15 billion, a P/E ratio of 47.90, a price-to-earnings-growth ratio of 2.40 and a beta of 1.77. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.60 and a current ratio of 2.21.

Lam Research (NASDAQ:LRCX) last released its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. Lam Research had a net margin of 29.66% and a return on equity of 60.60%. The company had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. During the same period in the prior year, the business earned $0.86 EPS. The firm’s quarterly revenue was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities research analysts predict that Lam Research will post 3.71 EPS for the current fiscal year.

Insider Transactions at Lam Research

In related news, Director Bethany Mayer sold 1,298 shares of the stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $159.99, for a total transaction of $207,667.02. Following the completion of the sale, the director directly owned 1,652 shares of the company’s stock, valued at $264,303.48. This trade represents a 44.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider Ava Harter sold 9,010 shares of the business’s stock in a transaction dated Monday, October 27th. The stock was sold at an average price of $157.47, for a total transaction of $1,418,804.70. Following the transaction, the insider owned 56,786 shares in the company, valued at approximately $8,942,091.42. This trade represents a 13.69% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 50,418 shares of company stock worth $7,667,305. Insiders own 0.31% of the company’s stock.

Institutional Investors Weigh In On Lam Research

A number of institutional investors have recently added to or reduced their stakes in LRCX. PMV Capital Advisers LLC purchased a new stake in shares of Lam Research in the fourth quarter valued at approximately $25,000. IMG Wealth Management Inc. purchased a new stake in shares of Lam Research during the 2nd quarter worth $26,000. Stance Capital LLC acquired a new position in shares of Lam Research during the 3rd quarter worth $26,000. Howard Hughes Medical Institute acquired a new position in shares of Lam Research during the 2nd quarter worth $27,000. Finally, Triumph Capital Management purchased a new position in shares of Lam Research in the 3rd quarter valued at about $27,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research News Summary

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: Stifel Nicolaus raised its Lam Research price target to $250 and kept a Buy rating, citing stronger WFE spending (up to ~10–15% in 2026) that supports higher sales/margins. Stifel Boosts LRCX PT to $250
• Positive Sentiment: Bank of America raised its price target to $245, reinforcing buy-side analyst momentum and expectations for sustained capital expenditure from major customers. BofA Increases LRCX PT to $245
• Positive Sentiment: Rothschild & Co Redburn lifted its target to $225 and maintained a Buy rating—another brokerage upgrade adding sell‑side conviction to the rally. Rothschild & Co Redburn Raises PT
• Positive Sentiment: Seeking Alpha upgraded LRCX (Buy), arguing a “WFE supercycle” driven by AI and memory supply constraints justifies higher EBITDA/FCF forecasts and a base‑case PT near $247 (bull case much higher). SA: WFE Supercycle Changes Valuation
• Positive Sentiment: Broad chip‑equipment optimism lifted peers as well — Barron’s notes TSMC’s heavy spending is boosting suppliers like Lam Research, supporting sectorwide upside. Barron’s: Chip Stocks Getting a Boost
• Neutral Sentiment: Zacks ran pieces assessing Lam as a momentum/analyst‑driven buy—useful framing for traders but largely commentary rather than new fundamental data. Zacks: Momentum Stock Analysis
• Neutral Sentiment: Market commentary/podcasts flagged Lam as a catalyst in early market rallies, reflecting broader equity flows into AI and chip‑equipment names. Wall Street Breakfast Podcast
• Negative Sentiment: Zacks flagged a risk: Lam expects China revenue to fall below 30% in 2026 due to export curbs — a potential headwind if China demand or access weakens, which could temper growth despite AI demand elsewhere. Zacks: China Revenue Risk

About Lam Research

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.